Rague J, Huang J, Khan S, Dubrovskaya Y, Press R & Safdar A. Initial High Serum (1, 3) β-D-Glucan (BDG) in Hospitalized Adult Patients: Impact on Treatment Outcomes and Hospital Mortality. (Abstract 51976). IDSA and SHEA Annual Meeting; IDWeek. October 7-11, 2015 San Diego, CA

/in /by

Taff J, Tang K, Dubrovskaya Y, Press R & Safdar A. Evaluation of Human Coronavirus HKU1, NL63, OC43 and C229E Infections in 176 Patients at a Tertiary Care Medical Center in New York. (Poster # V-1382) ASM’s Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) & International Society of Chemotherapy (ISC)’s International Congress of Chemotherapy and Infection (ICC). September 17–21, 2015 | San Diego, CA

/in /by

Khan S, Huang J, Rauge J, Dubrovskaya Y, Press R & Safdar A. Serum (1,3) β-D-Glucan (BDG) to Assess Response to Antifungal Therapy and Predict Short-term Mortality in 275 Patients at a Major University Medical Center in New York. (Poster # D-726) ASM’s Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) & International Society of Chemotherapy (ISC)’s International Congress of Chemotherapy and Infection (ICC). September 17–21, 2015 | San Diego, CA

/in /by

Taff J, Dubrovskaya Y, Kudlowitz D, Sartori D, Mulliken J & Safdar A. Risk Factors and Predictors for Lung Disease in Patients with Human Metapneumovius Infection at a Major University Hospital in New York. The 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Copenhagen, Denmark. April 25-28th, 2015.

/in /by

Safdar A. Successful Therapy with Aerosolized 7% Hypertonic Saline in Patients with Severe Refractory Pulmonary Nontuberculous Mycobacteriosis (pNTM). The 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Copenhagen, Denmark. April 25-28th, 2015.

/in /by

Safdar A. Challenges in effective treatment for patients with nontuberculous mycobacterial lung disease. The 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Copenhagen, Denmark. April 25-28th, 2015.

/in /by

Torres JA, Dubrovskaya Y, Teperman J, Press R & Safdar A. Serial Procalcitonin in Critically Ill Patients including Solid-Organ Transplantation (SOT) Recipients with Infection or Infection-Like Syndrome may Predict Outcomes. IDWeek 2014TM, Philadelphia, PA. October 8-12, 2014

/in /by

Dubrovskaya Y, Siegfried J, Flagiello T, Scipione MR, Chen D, Phillips M, Papadopoulos J, & Safdar A. Role of Metronidazole vs. Vancomycin as Initial Therapy in Hospitalized Patients with Mild to Moderate Clostridium difficile Infection (CDI) with NAP1 vs. non-NAP1 Disease. (45539). IDWeek 2014TM, Philadelphia, PA. October 8-12, 2014

/in /by

Safdar A, Goff D, Gallagher J, Hsu D, Eiland E, Hanrahan J, Smith P, Azie N. Antifungal Stewardship: The Clinician’s Perspective on Barriers to Implementation. IDWeek 2014TM, Philadelphia, PA. October 8-12, 2014

/in /by

Safdar A, Press R. Changing Trends Among 829 Candidemia Episodes During Past Fifteen Years at a Major University Hospital in New York City. (Abstract # K-1647) 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology (ASM). Washington, DC, September 5–9, 2014

/in /by